Dr. Samba Reddy

Biography

D. Samba Reddy is a Regents Professor at Texas A&M University in the Department of Neuroscience and Experimental Therapeutics and the Director of the Institute of Pharmacology and Neurotherapeutics. With over 25 years of experience, Reddy is a board-certified pharmacist-pharmacologist whose research focuses on new drug development for epilepsy and brain disorders. His lab develops innovative, disease-modifying therapies aimed at preventing the progression of epilepsy. Notable contributions include the discovery of neurosteroid replacement therapy (NRT) to manage seizures and mood disorders. Reddy's critical work led to the development of FDA-approved drugs such as brexanolone for postpartum depression and ganaxolone for epilepsy. An expert in pharmacology and therapeutics, he has authored over 230 papers and has presented numerous invited talks. Reddy also teaches medical and graduate courses on human pharmacology. He has received several prestigious awards, including being named a Fellow of the American Epilepsy Society and the American Association for the Advancement of Science. His contributions have significantly impacted healthcare, evidenced by his extensive research funded by NIH and DOD. Reddy is actively engaged in interdisciplinary projects leveraging artificial intelligence for smart therapies related to chronic brain disorders.

Research Interests

Experience

Awards